Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
108.9 USD | -1.47% | -0.85% | -11.63% |
May. 13 | US reclassification could drive fresh research funding into pot sector | RE |
May. 07 | Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.63% | 6.97B | |
+31.88% | 694B | |
+29.49% | 593B | |
-1.67% | 371B | |
+19.48% | 331B | |
+6.65% | 290B | |
+14.23% | 239B | |
-3.11% | 209B | |
+10.05% | 209B | |
+8.26% | 169B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Insider Sell: Jazz Pharmaceuticals